LSPN 19: Courts need to revisit patentability of diagnostic tests

26-04-2019

LSPN 19: Courts need to revisit patentability of diagnostic tests

motortion films / Shutterstock.com

US courts need to revisit the patentability of diagnostic tests under section 101, according to Memorial Sloan Kettering Cancer Center’s chief IP counsel.


patentability, diagnostic tests, section 101, Athena v Mayo, transplant, US Court of Appeals for the Federal Circuit, US Supreme Court, patent protection

LSIPR